Experimental evidence for the cardioprotective effects of red wine

Experimental and Clinical Cardiology

Volumn 12, Issue 1, 2007, Pages 5-10

  Das, Samarjit ^a   Santani, Dev D ^a   Dhalla, Naranjan S ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Alcohol; Antioxidants; Flavonoids; Polyphenols; Red wine

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A3 RECEPTOR; ALCOHOL; ANTHOCYANIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; BENZENE; CATECHIN; CINNAMIC ACID DERIVATIVE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FLAVONOID; GELATINASE B; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; NITRIC OXIDE; POLYPHENOL; PROANTHOCYANIDIN; PROTEIN C JUN; QUERCETIN; RESVERATROL; TANNIN DERIVATIVE; VASCULAR CELL ADHESION MOLECULE 1;

ALCOHOL CONSUMPTION; ANTIOXIDANT ACTIVITY; ARTERIOSCLEROSIS; CARDIOVASCULAR EFFECT; CELL MIGRATION; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; DRUG ABSORPTION; DRUG PROTEIN BINDING; GRAPE JUICE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RED WINE; REPERFUSION INJURY; REVIEW; SMOOTH MUSCLE FIBER; THROMBOCYTE AGGREGATION INHIBITION; VASODILATATION;

EID: 34147174939     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992;339:1523-6.
2. Hertog MG, Feskens EJ, Kromhout D. Antioxidant flavonols and coronary heart disease risk. Lancet 1997;349:699.
3. Das DK, Maulik N. Protection against free radical injury in the heart and cardiac performance. In: Exercise and Oxygen Toxicity, edited by Sen CK, Packer L, Hanninen O. Amsterdam: Elsevier Science, 1995:359-88.
4. Tosaki A, Bagchi D, Pali T Cordis GA, Das DK. Comparisons of ESR and HPLC methods for the detection of OH radicals in ischemic/reperfused hearts. A relationship between the genesis of free radicals and reperfusion arrhythmias. Biochem Pharmacol 1993;45:961-9.
5. Cordis GA, Maulik N, Das DK. Detection of oxidative stress in heart by estimating the dinitrophenylhydrazine derivative of malonaldehyde. J Mol Cell Cardiol 1995;27:1645-53.
6. Cordis GA, Maulik G, Bagchi D, Riedel W, Das DK. Detection of oxidative DNA damage to ischemic reperfused rat hearts by 8-hydroxydeoxyguanosine formation. J Mol Cell Cardiol 1998;30:1939-44.
7. Das S, Powell SR, Wang P, et al. Cardioprotection with palm tocotrienol: Antioxidant activity of tocotrienol is linked with its ability to stabilize proteasomes. Am J Physiol Heart Circ Physiol 2005;289:H361-7.
8. Waterhouse AL. Wine phenolics. Ann NY Acad Sci 2002;957:21-36.
9. Fuhrman B, Volkova N, Suraski A, Aviram M. White wine with red wine-like properties: Increased extraction of grape skin polyphenols improves the antioxidant capacity of the derived white wine. J Agric Food Chem 2001;49:3164-8.
10. Vinson JA, Hontz BA. Phenol antioxidant index: Comparative antioxidant effectiveness of red and white wines. J Agric Food Chem 1995;43:401-3.
11. Hennekens CH, Rosner B, Cole DS. Daily alcohol consumption and fatal coronary heart disease. Am J Epidermol 1978;107:196-200.
12. Yano K, Rhoads GG, Kagan A. Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii. N Engl J Med 1977;297:405-9.
13. Teissedre PL, Waterhouse AL. Inhibition of oxidation of human low-density lipoproteins by phenolic substances in different essential oils varieties. J Agric Food Chem 2000;48: 3801-5.
14. Howard A, Chopra M, Thurnham D, Strain J, Fuhrman B, Aviram M. Red wine consumption and inhibition of LDL oxidation: What are the important components? Med Hypotheses 2002;59:101-4.
15. Saucier CT, Waterhouse AL. Synergetic activity of catechin and other antioxidants. J Agric Food Chem 1999;47:4491-4.
16. Araim O, Ballantyne J, Waterhouse A, Sumpio BE. Inhibition of vascular smooth muscle cell proliferation with red wine and red wine polyphenols. J Vasc Surg 2002;35:1226-32.
17. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999;353:1547-57.
18. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000;355:675-87.
19. Yarnell JW, Evans AE. The Mediterranean diet revisited - towards resolving the (French) paradox. QJM 2000;93:783-5.
20. Kozararevic D, McGee D, Vojvodic N, et al. Frequency of alcohol consumption and morbidity and mortality: The Yugoslavia Cardiovascular Disease Study. Lancet 1980;1:613-6.
21. Marmot MG, Rose G, Shipley MJ, Thomas BJ. Alcohol and mortality: A U-shaped curve. Lancet 1981;1:580-3.
22. Shaper AG, Wannamethee G, Walker M. Alcohol and mortality in British men: Explaining the U-shaped curve. Lancet 1988;2:1267-73.
23. Boffetta F, Garfinkel L. Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study. Epidemiology 1990;1:342-8.
24. Klatsky AL, Friedman GD, Armstrong MA, Kipp H. Wine, liquor, beer, and mortality. Am J Epidemiol 2003;158:585-95.
25. Fuhrman B, Volkova N, Suraski A, Aviram M. White wine with red wine-like properties: Increased extraction of grape skin polyphenols improve the antioxidant capacity of the derived white wine. J Agric Food Chem 2001;49:3164-8.
26. Aviram M. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis and the antiatherogenicity of antioxidants. Eur J Clin Chem Clin Biochem 1996;34:599-608.
27. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997;272:20963-6.
28. Kaplan M, Aviram M. Oxidized low density lipoprotein: Atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase. Clin Chem Lab Med 1999;37:777-87.
29. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996;20:707-27.
30. Parthasarathy S, Santanam N, Auge N. Oxidized low-density lipoprotein, a two-faced Janus in coronary artery disease? Biochem Pharmacol 1998;56:279-84.
31. Fuhrman B, Aviram M. Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Curr Opin Lipidol 2001;12:41-8.
32. Nigdikar SV, Williams NR, Griffin BA, Howard AN. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr 1998;68:258-65.
33. Ehrenwald E, Chisolm GM, Fox PL. Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest 1994;93:1493-501.
34. Abu-Amsha R, Croft KD, Puddey IB, Proudfoot JM, Beilin LJ. Phenolic content of various beverages determines the extent of inhibition of human serum and low-density lipoprotein oxidation in vitro: Identification and mechanism of action of some cinnamic acid derivatives from red wine. Clin Sci (Lend) 1996;91:449-58.
35. Fuhrman B, Lavy A, Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr 1995;61:549-54.
36. Gorelik S, Lapidot T, Shaham I, et al. Lipid peroxidation and coupled vitamin oxidation in simulated and human gastric fluid inhibited by dietary polyphenols: Health implications. J Agric Food Chem 2005;53:3397-402.
37. Perret B, Ruidavets JB, Vieu C, et al. Alcohol consumption is associated with enrichment of high-density lipoprotein particles in polyunsaturated lipids and increased cholesterol esterification rate. Alcohol Clin Exp Res 2002;26:1134-40.
38. Araya J, Rodrigo R, Orellana M, Rivera G. Red wine raises plasma HDL and preserves long-chain polyunsaturated fatty acids in rat kidney and erythrocytes. Br J Nutr 2001;86:189-95.
39. Cordova AC, Jackson LS, Berke-Schlessel DW, Sumpio BE. The cardiovascular protective effect of red wine. J Am Coll Surg 2005;200:428-39.
40. Marques-Vidal P, Cambou JP, Nicaud V, et al. Cardiovascular risk factors and alcohol consumption in France and Northern Ireland. Atherosclerosis 1995;115:225-32.
41. Rivard A, Andres V. Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases. Histol Histopathol 2000;15:557-71.
42. Zou J, Huang Y, Cao K, et al. Effect of resveratrol on intimal hyperplasia after endothelial denudation in an experimental rabbit model. Life Sci 2000;68:153-63.
43. Iijima K, Yoshizumi M, Hashimoto M, et al. Red wine polyphenols inhibit proliferation of vascular smooth muscle cells and downregulate expression of cyclin A gene. Circulation 2000;101:805-11.
44. Moon SK, Cho GO, Jung SY, et al. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: Role of ERK1/2, cell-cycle regulation, and matrix metalloprotemase-9. Biochem Biophys Res Commun 2003;301:1069-78.
45. Das S, Bertelli AA, Bertelli A, Maulik N, Das DK. Anti-inflammatory action of resveratrol: A novel mechanism of action. Drugs Exp Clin Res 2006 not published yet.
46. Demrow HS, Slane PR, Folts JD. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation 1995;91:1182-8.
47. Pace-Asciak CR, Hahn S, Diamandis EF, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Clin Chim Acta 1995;235:207-19.
48. Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP, Goldberg DM. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta 1996;246:163-82.
49. Seigneur M, Bonnet J, Dorian B, et al. Effect of the consumption of alcohol, white wine, and red wine on platelet function and serum lipids. J Appl Cardiol 1990;5:215-22.
50. Grassi GM, Somers VK, Renk WS, Abboud FM, Mark AL. Effects of alcohol intake on blood pressure and sympathetic nerve activity in normotensive humans: A preliminary report. J Hypertens Suppl 1989;7:S20-1.
51. Altura BM, Zou LY, Altura BT, Jelicks L, Wittenberg BA, Gupta RK. Beneficial vs. detrimental actions of ethanol on heart and coronary vascular muscle: Roles of Mg2+ and Ca2+. Alcohol 1996;13:499-513.
52. Su CY, Chong KY, Owen OE, Dillmann WH, Chang C, Lai CC. Constitutive and inducible hsp70s are involved in oxidative resistance evoked by heat shock or ethanol. J Mol Cell Cardiol 1998;30:587-98.
53. Sato M, Maulik N, Das DK. Cardioprotection with alcohol: Role of both alcohol and polyphenolic antioxidants. Ann NY Acad Sci 2002;957:122-35.
54. Miyamae M, Camacho SA, Zhou HZ, Diamond I, Figueredo VM. Alcohol consumption reduces ischemia-reperfusion injury by species-specific signaling in guinea pigs and rats. Am J Physiol 1998;275:H50-6.
55. Goldberg DM, Tsang E, Karumanchiri A, Diamandis E, Soleas O, Ng E. Method to assay the concentrations of phenolic constituents of biological interest in wines. Anal Chem 1996;68:1688-94.
56. Ray PS, Maulik G, Cordis GA, Bertelli AAE, Bertelli A, Das DK. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic Biol Med 1999;27:160-9.
57. Das S, Cordis GA, Maulik N, Das DK. Pharmacological preconditioning with resveratrol: Role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation. Am J Physiol Heart Circ Physiol 2005;288:H328-35.
58. Das S, Tosaki A, Bagchi D, Maulik N, Das DK. Resveratrol-mediated activation of cAMP response element-binding protein through adenosine A3 receptor by Akt-dependent and independent pathways. J Pharmacol Exp Ther 2005;314:762-9.
59. Das S, Alagappan VK, Bagchi D, Sharma HS, Maulik N, Das DK. Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: A potential mechanism for resveratrol preconditioning of the heart. Vascul Pharmacol 2005;42:281-9.
60. Hattori R, Otani H, Maulik N, Das DK. Pharmacological preconditioning with resveratrol: Role of nitric oxide. Am J Physiol Heart Circ Physiol 2002;282:H1988-95.
61. Juan SH, Cheng TH, Lin HC, Chu YL, Lee WS. Mechanism of concentration-dependent induction of heme oxygenase-1 by resveratrol in human aortic smooth muscle cells. Biochem Pharmacol 2005;69:41-8.
62. Sato M, Maulik G, Ray PS, Bagchi D, Das DK. Cardioprotective effects of grape seed proanthocyanidin against ischemic reperfusion injury. J Mol Cell Cardiol 1999;31:1289-97.
63. Bagchi D, Sen CK, Ray SD, et al. Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat Res 2003;523-524:87-97.
64. Sato M, Bagchi D, Tosaki A, Das DK. Grape seed proanthocyanidin reduces cardiomyocyte apoptosis by inhibiting ischemia/reperfusion-induced activation of JNK-1 and C-JUN. Free Radic Biol Med 2001;31:729-37.
65. Shao ZH, Vanden Hoek TL, Xie J, et al. Grape seed proanthocyanidins induce pro-oxidant toxicity in cardiomyocytes. Cardiovasc Toxicol 2003;3:331-9.
66. Sumpio BE, Oluwole B, Wang X, Awolesi M. Regulation of nitric oxide synthase expression and activity by hemodynamic forces. In; The Pathophysiology and Clinical Applications of Nitric Oxide. United Kingdom: Hardwood Academic Publishers, 1998:171-93.
67. Wallerath T, Deckert G, Ternes T, et al. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002;106:1652-8.